(6R,7S)-7-({[4-(2-Amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic a cid(CAS: 69712-56-7)

This compound is subject to regulatory guidelines including REACH in Europe, GHS for hazardous labeling, and FDA/EPA requirements for chemical substances and their environmental release. Specific safety data sheets and material safety data sheets (MSDS) must be consulted for detailed compliance information.

Alternative reagents and compounds, such as related tetrazoles or similar dithietan derivatives, can be considered. Common substitutes include analogs with similar functional groups, which may offer comparable or different properties for various applications.

Research trends indicate increased interest in developing novel tetrazole compounds for pharmaceutical and medicinal uses. Market dynamics show growing demand for specialized chemical intermediates in drug discovery and synthesis. Emerging studies focus on the compound's potential in targeted drug delivery systems and therapeutic applications.

Waste containing this compound should be collected in sealed containers and disposed of through professional waste disposal services. Incineration or chemical treatment methods may be employed, ensuring compliance with environmental regulations. Proper labeling and documentation are essential for safe handling and disposal.